Glenmark Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE935A01035
  • NSEID: GLENMARK
  • BSEID: 532296
INR
1,965.75
-8.4 (-0.43%)
BSENSE

Dec 05

BSE+NSE Vol: 4.41 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
28.22
28.22
28.22
28.22
28.22
28.22
Share Warrants & Outstandings
Total Reserve
8,821.22
7,819.71
9,445.71
9,058.43
7,036.41
6,042.29
Shareholder's Funds
8,849.44
7,847.93
9,473.92
9,086.65
7,064.63
6,070.51
Minority Interest
-0.37
-0.38
365.34
351.47
-0.35
-0.39
Long-Term Borrowings
512.70
0.00
3,997.72
2,571.74
3,888.82
4,426.04
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
512.70
0.00
3,997.72
2,571.74
3,888.82
4,426.04
Deferred Tax Assets / Liabilities
-1,065.52
-1,049.44
-1,762.96
-1,654.63
-1,505.92
-1,439.26
Other Long Term Liabilities
662.17
692.21
591.8
352.5
420.72
429.27
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
109.35
-357.23
2,680.97
1,269.61
2,803.62
3,033.01
Current Liabilities
Trade Payables
2,579.53
2,535.93
2,391.86
2,288.66
2,237.77
2,125.84
Other Current Liabilities
1,109.92
1,650.94
1,650.54
810.78
650.31
1,042.34
Short Term Borrowings
1,681.49
990.60
495.58
1,098.61
798.61
442.60
Short Term Provisions
596.08
641.12
507.55
491.38
514.33
515.20
Total Current Liabilities
5,967.02
5,818.59
5,045.53
4,689.43
4,201.02
4,125.98
Total Liabilities
14,925.44
13,308.90
17,565.76
15,397.17
14,068.91
13,229.10
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
9,719.92
9,026.27
10,733.90
9,725.06
8,304.81
8,269.83
Less: Accumulated Depreciation
5,476.31
5,015.19
4,768.34
4,086.88
3,441.14
3,241.28
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
4,243.62
4,011.09
5,965.56
5,638.18
4,863.67
5,028.56
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
541.99
419.32
1,115.18
921.09
1,217.79
1,090.64
Intangible assets under development
292.84
242.56
136.08
88.78
163.88
131.25
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
56.35
789.66
44.65
49.62
24.62
24.59
Long Term Loans & Advances
242.74
211.70
190.29
161.38
146.29
123.97
Other Non Current Assets
9.23
7.42
3.46
6.70
27.89
26.49
Total Non-Current Assets
5,629.98
5,880.82
7,692.04
7,114.82
6,709.33
6,425.49
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
3,028.53
2,513.05
2,977.79
2,499.83
2,276.83
2,135.62
Sundry Debtors
3,341.95
1,858.41
4,098.61
3,101.14
2,572.05
2,408.96
Cash and Bank
1,705.23
1,659.46
1,469.70
1,411.52
1,139.16
1,111.24
Other Current Assets
144.97
178.21
360.76
297.46
324.60
237.15
Short Term Loans and Advances
1,074.79
1,218.95
966.86
972.41
1,046.93
910.64
Total Current Assets
9,295.47
7,428.08
9,873.72
8,282.35
7,359.58
6,803.62
Net Current Assets (Including Current Investments)
3,328.44
1,609.49
4,828.19
3,592.92
3,158.56
2,677.63
Total Current Assets Excluding Current Investments
9,295.47
7,428.08
9,873.72
8,282.35
7,359.58
6,803.62
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
14,925.44
13,308.90
17,565.76
15,397.17
14,068.91
13,229.10
Contingent Liabilities
800.26
1,063.30
336.69
361.31
384.20
271.21
Total Debt
2,194.20
990.60
4,202.14
3,670.35
4,687.43
4,102.55
Book Value per share (adjusted)
313.6
278.11
335.75
322.03
250.37
215.14
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 121.50% vs -77.22% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is -4.34% vs 16.97% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 8.02% vs -37.43% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is -92.86% vs 1,668.56% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 25.14% vs -24.77% in Mar 2024

Compare Balance Sheet Results of Glenmark Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
28.22
0
28.22
0.00%
Share Warrants & Outstandings
Total Reserve
8,821.22
0
8,821.22
0.00%
Shareholder's Funds
8,849.44
0
8,849.44
0.00%
Minority Interest
-0.37
0
-0.37
0.00%
Long-Term Borrowings
512.70
0
512.70
0.00%
Secured Loans
0.00
0
0.00
0.00%
Unsecured Loans
512.70
0
512.70
0.00%
Deferred Tax Assets / Liabilities
-1,065.52
0
-1,065.52
0.00%
Other Long Term Liabilities
662.17
0
662.17
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
0.00
0
0.00
0.00%
Total Non-Current Liabilities
109.35
0
109.35
0.00%
Current Liabilities
Trade Payables
2,579.53
0
2,579.53
0.00%
Other Current Liabilities
1,109.92
0
1,109.92
0.00%
Short Term Borrowings
1,681.49
0
1,681.49
0.00%
Short Term Provisions
596.08
0
596.08
0.00%
Total Current Liabilities
5,967.02
0
5,967.02
0.00%
Total Liabilities
14,925.44
0
14,925.44
0.00%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
9,719.92
0
9,719.92
0.00%
Less: Accumulated Depreciation
5,476.31
0
5,476.31
0.00%
Less : Impairment of Assets
0.00
0
0.00
0.00%
Net Block
4,243.62
0
4,243.62
0.00%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
541.99
0
541.99
0.00%
Intangible assets under development
292.84
0
292.84
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
56.35
0
56.35
0.00%
Long Term Loans & Advances
242.74
0
242.74
0.00%
Other Non Current Assets
9.23
0
9.23
0.00%
Total Non-Current Assets
5,629.98
0
5,629.98
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0
0.00
0.00%
Inventories
3,028.53
0
3,028.53
0.00%
Sundry Debtors
3,341.95
0
3,341.95
0.00%
Cash and Bank
1,705.23
0
1,705.23
0.00%
Other Current Assets
144.97
0
144.97
0.00%
Short Term Loans and Advances
1,074.79
0
1,074.79
0.00%
Total Current Assets
9,295.47
0
9,295.47
0.00%
Net Current Assets (Including Current Investments)
3,328.44
0
3,328.44
0.00%
Total Current Assets Excluding Current Investments
9,295.47
0
9,295.47
0.00%
Miscellaneous Expenses not written off
0.00
0
0.00
0.00%
Total Assets
14,925.44
0
14,925.44
0.00%
Contingent Liabilities
800.26
0
800.26
0.00%
Total Debt
2,194.20
0
2,194.20
0.00%
Book Value per share (adjusted)
313.60
0
313.60
0.00%
Annual - Borrowings
Borrowings 2,194.19 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 121.50% vs -77.22% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 662.17 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -4.34% vs 16.97% in Mar 2024

Annual - Fixed Assets
Fixed Assets 4,785.61 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 8.02% vs -37.43% in Mar 2024

Annual - Investments
Investments 56.35 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -92.86% vs 1,668.56% in Mar 2024

Annual - Current Assets
Current Assets 9,295.47 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 25.14% vs -24.77% in Mar 2024